Hong Kong stock market abnormality | Bei Bo medicine-B (02142.HK) rose more than 6% in early trading. Its subsidiary, Nona Bio, has signed a non-exclusive licensing agreement with Pfizer.

According to the Zhitong finance and economics app, Hapo Medicine-B (02142.HK) rose over 6% in the morning session. As of the time of writing, it was up 6.16% to 14.68 Hong Kong dollars with a trading volume of 8.0214 million Hong Kong dollars.